Upadacitinib RC00795
14 Inquiries
1310726-60-3
Pharmaceutical Grade
99%
中国
Royalchem
25kg/drum
2025-12-31
Pharmaceutical intermediates
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Upadacitinib
Other Name:Upadacitinib;Upadacitinib (ABT-494);ABT-494 (Upadacitinib);Upadacitinib (Rinvoq);ABT-494; ABT494; ABT 494;CS-2730;(3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide, Upadacitinib;1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, (3S,4R)-
CAS No.:1310726-60-3
Molecular Formula:C17H19F3N6O
InChIKeys:WYQFJHHDOKWSHR-MNOVXSKESA-N
Molecular Weight:380.37
Exact Mass:380.37
EC Number:213-161-9
Color/Form:White to off-white
Categories:
Characteristics-
PSA:
78.32
XLogP3:3.2367
Density:1.56±0.1 g/cm3(Predicted)
PKA:11.89±0.60(Predicted)
Critical Temperature & Pressure:Store at -20°C
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Pharmaceutical intermediates
-
Location:
Room 336, Building 7, No. 177 Xingqiao North Road, Xingqiao Street, Linping District, Hangzhou
-
Payment Terms:
TT against copy of documents,D/P,L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
14
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
Less than 5
-
Year of Establishment:
2025
-
-
Inquiry History14 Inquiries
Country Product Purchase Quantity Date Posted
India
Upadacitinib
30.00 KG May 20, 2024
India
Upadacitinib - ABT- 494
5.00 KG Jan 19, 2024
India
Upadacitinib
5 KG Jan 17, 2024
India
Upadacitinib
10.00 KG Mar 6, 2024
Hongkong, China
Upadacitinib
50 MG Apr 7, 2026
India
Upadacitinib
100 G Nov 24, 2025
India
Upadacitinib
5 KG Nov 29, 2023
Pakistan
UPADACITINIB
7 KG Oct 8, 2023
Pakistan
UPADACITINIB
0.51 KG Feb 25, 2026
India
Upadacitinib
1000.00 KG Feb 13, 2025
Pakistan
Upadacitinib
1 KG Feb 17, 2025
India
URSODEOXYCHOLIC ACID
10.00 KG Mar 6, 2024
India
Acarbose
10.00 KG Mar 6, 2024
India
Ripretinib
10.00 KG Mar 6, 2024 Post an enquiry for this product